Stanford Strikes Analytics Partnership to Evaluate COVID-19 Health Outcomes

By Shania Kennedy

– Researchers from Stanford’s Heart for Inhabitants Well being Sciences will make the most of healthcare analytics firm Komodo Well being’s information platform to assist research centered on well being outcomes associated to the coronavirus pandemic.

Preliminary research will concentrate on evaluating the real-world influence of COVID-19 on well being outcomes throughout numerous populations, together with analysis into pandemic-related care disparities and the relationships between social determinants of well being (SDOH), COVID testing, and vaccinations. Researchers are additionally within the pandemic’s influence on most cancers survival, remedy, and outcomes.

Related Articles

Earlier inhabitants well being analysis has proven that geographic components, equivalent to residing in a rural group, and racial or ethnic background, like being Black or Hispanic, are correlated with elevated well being disparities and adversarial outcomes associated to COVID-19. Efforts to make use of information analytics and SDOH to deal with these disparities and promote well being fairness are ongoing.

Along with inhabitants well being research, researchers will take a look at coronavirus-related analysis in infectious illness, pediatrics, surgical procedure, inhabitants well being, obstetrics and gynecology, and different areas.

Komodo’s platform, Sentinel, makes use of real-world, de-identified affected person information and synthetic intelligence-driven (AI) analytics to assist researchers generate insights. In accordance with the press launch, the platform affords a number of analytics modules that researchers can use to construct algorithms, design scientific trials, consider advanced illness patterns, and discover well being disparities.

Stanford Drugs’s partnership with Komodo is the newest within the group’s efforts to advance COVID-19 analysis.

In April 2020, Stanford launched a consortium with the Scripps Analysis Translational Institute (SRTI) geared toward finding out how wearables may very well be used to deal with COVID-19. By way of the consortium, the 2 organizations partnered with Fitbit to mixture information from mHealth packages researching this space.

The consortium builds on two initiatives beforehand launched by Stanford and SRTI. Stanford’s Healthcare Innovation Lab launched the COVID-19 Wearables Examine, which centered on figuring out if wearables information may very well be used to foretell the pre-symptomatic onset of the illness. SRTI had unveiled DETECT, a nationwide venture to judge how wearables information may very well be built-in into public well being surveillance.

Stanford Drugs and Fitbit additionally collaborated on associated analysis in April 2021.

The 2 partnered with the Pacific-12 (Pac-12) athletic convention, which contains over 1,000 school athletes in sports activities equivalent to basketball, soccer, soccer, and volleyball, to review the worth of wearables in figuring out and monitoring infectious ailments like COVID-19.

Over the course of the examine, which befell by way of the tip of 2021, collaborating athletes have been required to put on a Fitbit Sense smartwatch and endure frequent coronavirus testing. Earlier analysis has proven that day-to-day modifications in clinically related well being metrics can point out the earliest indicators of an infection and sickness earlier than signs seem. This analysis was designed to construct on these insights, however outcomes haven’t but been printed.

Source link

Related Articles

Back to top button